Synthesis and metabolic profile of Cl‐966: A potent, orally‐active inhibitor of GABA uptake
- 1 January 1990
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 21 (3) , 189-193
- https://doi.org/10.1002/ddr.430210305
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- GABA uptake inhibitors: relevance to antiepileptic drug researchEpilepsy Research, 1987
- Orally Active and Potent Inhibitors of γ-Aminobutyric Acid UptakeJournal of Medicinal Chemistry, 1985
- Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administrationEuropean Journal of Pharmacology, 1983
- Synthetic analogs for the study of GABA as a neurotransmitterMedicinal Research Reviews, 1983
- GABA and “neuro-cardiovascular” mechanismsNeurochemistry International, 1981
- .gamma.-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspectsJournal of Medicinal Chemistry, 1981
- Gaba receptor pharmacology functional considerationsBiochemical Pharmacology, 1981
- New anticonvulsants: Schiff bases of .gamma.-aminobutyric acid and .gamma.-aminobutyramideJournal of Medicinal Chemistry, 1980
- Influence of inhibitors of the high affinity GABA uptake on seizure thresholds in miceNeuropharmacology, 1979
- Uptake and metabolism of γ-aminobutyric acid by neurones and glial cellsBiochemical Pharmacology, 1975